Herold Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.77M Buy
15,405
+271
+2% +$63.1K 0.83% 33
2025
Q4
$3.13M Sell
15,134
-337
-2% -$66.6K 0.7% 39
2025
Q3
$2.87M Sell
15,471
-363
-2% -$62.2K 0.66% 43
2025
Q2
$2.42M Sell
15,834
-2,104
-12% -$323K 0.51% 59
2025
Q1
$2.98M Sell
17,938
-310
-2% -$48.5K 0.65% 42
2024
Q4
$2.64M Sell
18,248
-9
-0% -$1.4K 0.58% 50
2024
Q3
$2.96M Sell
18,257
-249
-1% -$39.7K 0.64% 43
2024
Q2
$2.71M Sell
18,506
-1,165
-6% -$173K 0.63% 43
2024
Q1
$3.11M Buy
19,671
+96
+0.5% +$15.3K 0.75% 35
2023
Q4
$3.07M Sell
19,575
-115
-0.6% -$17.6K 0.85% 29
2023
Q3
$3.07M Buy
19,690
+628
+3% +$104K 0.93% 25
2023
Q2
$3.16M Buy
19,062
+17
+0.1% +$2.74K 0.97% 22
2023
Q1
$2.95M Buy
19,045
+674
+4% +$109K 1.02% 22
2022
Q4
$3.25M Buy
18,371
+902
+5% +$156K 1.37% 17
2022
Q3
$2.85M Buy
17,469
+251
+1% +$42.5K 1.37% 14
2022
Q2
$3.06M Buy
17,218
+251
+1% +$44.7K 1.36% 12
2022
Q1
$3.01M Sell
16,967
-279
-2% -$47.5K 1.07% 16
2021
Q4
$2.95M Hold
17,246
1.15% 17
2021
Q3
$2.79M Buy
+17,246
New +$2.94M 1.08% 14

Other funds holding JNJ

Herold Advisors's JNJ Position: Q1 2026 in Review

Herold Advisors increased its Johnson & Johnson (JNJ) stake by 1.8% in Q1 2026, buying an estimated $63.1K and bringing the position to 15,405 shares worth $3.77M. The position accounts for 0.83% of the portfolio, ranked #33.

Herold Advisors first reported a position in JNJ in Q3 2021 and has held it in 19 quarters since. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Herold Advisors held 15,405 shares of Johnson & Johnson worth $3.77M as of Q1 2026.
  • Herold Advisors bought 271 Johnson & Johnson shares in Q1 2026, an estimated $63.1K.
  • Johnson & Johnson made up 0.83% of Herold Advisors's portfolio in Q1 2026, its #33 holding.
  • Herold Advisors first reported a position in Johnson & Johnson in Q3 2021 and has held it in 19 quarters since.
  • 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Herold Advisors's 13F filing for Q1 2026, filed 15 May 2026.